Science
Swiss Study to Prospectively Assess Value of Multi-Omic, Functional Tumor Profiling – Precision Oncology News
The TuPro study will evaluate whether a comprehensive suite of routine and emerging tests can add value to treatment decision making and improve outcomes.
This article has been updated with the number of patients involved in the study and timeline details.
NEW YORK A group of researchers in Switzerland has set out to show the feasibility of incorporating a comprehensive suite of tumor profiling technologies into the treatment decision-making process for cancer patients and prove that such a multi-omics approach will add value over standard approaches and improve precision therapy decisions.
The researchers outlined the design and aims of the Tumor…
-
General8 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General20 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News23 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’